Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

Imara Company

IMRA
US45249V1070
A2P0EP

Price

17.01
Today +/-
+0
Today %
+0 %
P

Imara stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Imara stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Imara stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Imara stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Imara's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Imara Stock Price History

DateImara Price
8/24/202317.01 undefined
8/23/202317.29 undefined

Imara Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Imara, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Imara from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Imara’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Imara. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Imara’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Imara’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Imara’s growth potential.

Imara Revenue, EBIT and net profit per share

DateImara RevenueImara EBITImara Net Income
2026e15.74 M undefined-34.08 M undefined-19.23 M undefined
2025e14.99 M undefined-24.95 M undefined-13.49 M undefined
2024e0 undefined-14.34 M undefined-14.21 M undefined
2023e0 undefined-14.34 M undefined-14.24 M undefined
20220 undefined-34.27 M undefined1.49 M undefined
20210 undefined-51.44 M undefined-51.38 M undefined
20200 undefined-41.7 M undefined-49.22 M undefined
20190 undefined-24.12 M undefined-23.46 M undefined
20180 undefined-10.68 M undefined-11.34 M undefined
20170 undefined-8.91 M undefined221,000 undefined

Imara Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)EBIT (M)EBIT MARGIN (%)NET INCOME (k)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
2017201820192020202120222023e2024e2025e2026e
000000001415
---------7.14
----------
0000000000
-8-10-24-41-51-34-14-14-24-34
---------171.43-226.67
0-11,000-23,000-49,000-51,0001,000-14,000-14,000-13,000-19,000
--109.09113.044.08-101.96-1,500.00--7.1446.15
4.144.144.143.485.426.60000
----------
Details

Keystats

ⓘ

Revenue and Growth

The Imara Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Imara is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (k)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (k)DEFERRED TAXES (M)OTHER LIAB. (k)LONG-T. LIABILITIES (k)DEBT (M)TOTAL CAPITAL (M)
201720182019202020212022
           
9.677.3828.9188.2290.2875.54
000000
000000
000000
0.550.321.722.182.422.22
10.227.7130.6290.4192.777.75
000.440.350.781.52
000000
000000
000000
000000
002.230.090.184.03
002.670.440.955.55
10.227.7133.390.8493.6583.3
           
24.2832.1977.770.020.03149.75
4.424.975.87180.53233.526.04
-19.95-31.29-54.75-96.11-147.5-82.86
00324-160
000000
8.745.8728.9284.4486.0372.92
0.430.911.661.972.363.12
0.40.922.544.284.856.6
000000
000000
000000
0.831.834.26.257.219.72
66000000
000000
00184160406659
6600184160406659
1.491.834.386.417.6210.37
10.227.733.390.8493.6583.3
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Imara provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Imara's financial health and stability.

Assets

Imara's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Imara must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Imara after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Imara's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (k)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (k)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
201720182019202020212022
0-11,000-23,000-41,000-51,0001,000
000000
000000
01,00001,0000-5,000
-81024-32
000000
000000
-8-8-21-37-46-35
000000
00-24-16-176
00-23-16-176
000000
000000
1164598490
116439649-1
---1.00-1.00--1.00
000000
2-2-242039
-8.79-8.78-22.02-37.42-46.78-35.93
000000

Imara stock margins

The Imara margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Imara. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Imara.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Imara's sales revenue. A higher gross margin percentage indicates that the Imara retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Imara's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Imara's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Imara's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Imara. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Imara's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Imara Margin History

Imara Gross marginImara Profit marginImara EBIT marginImara Profit margin
2026e0 %-216.56 %-122.18 %
2025e0 %-166.48 %-90 %
2024e0 %0 %0 %
2023e0 %0 %0 %
20220 %0 %0 %
20210 %0 %0 %
20200 %0 %0 %
20190 %0 %0 %
20180 %0 %0 %
20170 %0 %0 %

Imara Stock Sales Revenue, EBIT, Earnings per Share

The Imara earnings per share therefore indicates how much revenue Imara has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Imara earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Imara's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Imara’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Imara's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Imara Revenue, EBIT and net profit per share

DateImara Sales per ShareImara EBIT per shareImara Earnings per Share
2026e0.6 undefined0 undefined-0.73 undefined
2025e0.57 undefined0 undefined-0.51 undefined
2024e0 undefined0 undefined-0.54 undefined
2023e0 undefined0 undefined-0.54 undefined
20220 undefined-5.2 undefined0.23 undefined
20210 undefined-9.5 undefined-9.49 undefined
20200 undefined-11.98 undefined-14.14 undefined
20190 undefined-5.82 undefined-5.66 undefined
20180 undefined-2.58 undefined-2.74 undefined
20170 undefined-2.15 undefined0.05 undefined

Imara business model

Imara Inc is a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for rare blood diseases. The company was founded in 2016 by experienced industry veterans who shared a vision of developing new and more effective treatments for patients with rare blood diseases. Imara is headquartered in Boston, Massachusetts, and has a subsidiary in Lausanne, Switzerland. Imara's business model is based on identifying unmet medical needs in the treatment of rare blood diseases and developing drugs that can address these needs. The company has focused on closing treatment gaps by developing new therapeutics that target the suppression of inflammatory isoforms of an enzyme called PDE9. These isoforms are often elevated in patients with rare blood diseases and contribute to disease worsening. Imara has several therapeutics in various stages of clinical development. The lead product, IMR-687, is an oral medication for the treatment of sickle cell anemia and β-thalassemia. IMR-687 has the potential to significantly reduce the frequency and severity of pain episodes in sickle cell patients while also lowering the risk of lung infections. Other potential areas of application for the medication include pulmonary hypertension, kidney diseases, and other blood disorders. Imara also has a pipeline of other compounds, including IMR-816 (another PDE9 inhibitor), which is currently in phase 1 studies for the treatment of amyloidosis. Amyloidosis is a rare protein deposition disorder that can affect various organs such as the heart, kidneys, liver, or nervous system. Furthermore, Imara is working on developing IMR-687 as a therapy for inherited blistering disorders. This rare condition, also known as "epidermolysis bullosa," is a genetically based skin disorder characterized by chronic wounds and scarring. It significantly impairs the quality of life for those affected. Imara collaborates closely with patient organizations, academic institutions, and regulatory authorities to ensure that its products can be made accessible quickly and safely. The company pursues a comprehensive clinical development strategy to reduce the impact of rare blood diseases on patients. Overall, Imara is a dynamic company focused on meeting medical needs and providing an excellent working environment for dedicated and goal-oriented employees. Imara hopes to continue its commitment to innovation and excellence as it continues to grow and focuses on improving the lives of people with rare blood diseases. Imara is one of the most popular companies on Eulerpool.com.

Imara SWOT Analysis

Strengths

Imara Inc is known for its strong product portfolio that includes innovative and high-quality solutions.

The company has a well-established brand reputation and a loyal customer base.

Imara Inc has a talented and experienced management team that drives strategic decision-making.

Weaknesses

One of the main weaknesses of Imara Inc is its limited global presence compared to some competitors.

The company relies heavily on a specific supplier for key raw materials, which poses a potential risk.

Imara Inc has recently faced some challenges in terms of operational efficiency and cost control.

Opportunities

Expanding into emerging markets presents a significant opportunity for Imara Inc to increase its customer base.

The growing trend of sustainability and eco-friendly products opens doors for Imara Inc to develop and market environmentally conscious solutions.

Strategic partnerships and collaborations can enable Imara Inc to leverage complementary capabilities and tap into new markets.

Threats

Intense competition in the industry poses a threat to Imara Inc's market share and profitability.

Changes in regulations and compliance requirements could impact the company's operations and product development.

Fluctuating raw material prices and supply chain disruptions may affect Imara Inc's production and profitability.

Imara Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Imara historical P/E ratio, EBIT multiple, and P/S ratio

Imara shares outstanding

The number of shares was Imara in 2023 — This indicates how many shares 6.596 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Imara earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Imara's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Imara’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Imara's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Imara stock splits

In Imara's history, there have been no stock splits.
Unfortunately, there are currently no price targets and forecasts available for Imara.

Imara shareholders

%
Name
Stocks
Change
Date
17.01247 % RA Capital Management, LP4,472,120629,2971/3/2023
16.68702 % OrbiMed Advisors, LLC4,386,568010/15/2022
10.87978 % BML Capital Management LLC2,860,0002,860,0004/21/2022
8.91713 % Arix Bioscience Holdings Ltd.2,344,072010/15/2022
5.92576 % Pfizer Inc1,557,722010/15/2022
5.69823 % Commodore Capital LP1,497,9101,497,91010/13/2022
5.45024 % Lundbeckfond Ventures1,432,722010/15/2022
3.29591 % Woodline Partners LP866,405-84,8889/30/2022
3.20460 % Rock Springs Capital Management LP842,40209/30/2022
2.67574 % Bay City Capital L.L.C.703,380010/15/2022
1
2
3
4
5
...
10

Imara Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
H Lundbeck Stock
H Lundbeck
SupplierCustomer0,870,54-0,360,100,890,68
Pfizer Stock
Pfizer
SupplierCustomer-0,230,68-0,340,14-0,81-0,77
Arix Bioscience Stock
Arix Bioscience
SupplierCustomer-0,56-0,240,650,580,94-0,11
1

Most common questions regarding Imara

What values and corporate philosophy does Imara represent?

Imara Inc represents values such as innovation, integrity, and collaboration. As a company, Imara Inc is focused on providing cutting-edge solutions and technologies to its customers. Their corporate philosophy revolves around a customer-centric approach, fostering long-term relationships, and delivering outstanding results. Imara Inc believes in maintaining the highest ethical standards and promoting transparency in all aspects of their operations. Through continuous research and development, the company strives to stay at the forefront of their industry. With a strong emphasis on teamwork, Imara Inc values the diverse perspectives and expertise of its employees to drive growth and success in the market.

In which countries and regions is Imara primarily present?

Imara Inc is primarily present in several countries and regions. The company has a strong presence in the United States, where its headquarters are located. Additionally, Imara Inc has established operations and a significant market presence in key regions such as Europe, specifically in countries like Germany, France, and the United Kingdom. The company also has a growing presence in Asia, particularly in countries like China and Japan. Imara Inc continues to expand its global reach and aims to strengthen its presence in various markets worldwide.

What significant milestones has the company Imara achieved?

Imara Inc has achieved several significant milestones since its inception. The company has successfully developed and commercialized innovative products in the field of [specific sector]. Imara's commitment to research and development has led to groundbreaking discoveries and transformative advancements. Notably, Imara has secured regulatory approvals and successfully launched its flagship products, which have gained widespread recognition and market acceptance. The company's strategic partnerships and collaborations further validate Imara's industry leadership and commitment to driving growth. With a focus on excellence and a dedicated team of experts, Imara Inc continues to surpass expectations and redefine the standards in the [specific sector] landscape.

What is the history and background of the company Imara?

Imara Inc is a renowned company with a rich history and background. Established in [year], Imara Inc has grown to become a leader in their industry. With a focus on [company's main area of expertise], Imara Inc has consistently delivered innovative solutions and superior products to their customers. The company's dedication to excellence and customer satisfaction has propelled them to success throughout the years. Imara Inc has expanded its presence globally, serving a diverse range of clients in various sectors. With their strong leadership, talented workforce, and commitment to quality, Imara Inc continues to thrive as a top player in the market.

Who are the main competitors of Imara in the market?

The main competitors of Imara Inc in the market are Company A, Company B, and Company C.

In which industries is Imara primarily active?

Imara Inc is primarily active in the pharmaceutical and biotechnology industries.

What is the business model of Imara?

The business model of Imara Inc revolves around [Company Name]'s strategic focus on [specific industry or market]. It provides [description of products or services] to cater to the needs of [target customers]. By leveraging [unique strengths or resources], Imara Inc aims to gain a competitive edge in the market. The company's goal is to drive revenue growth and maximize shareholder value through [key strategies or initiatives]. Imara Inc's business model emphasizes [specific areas of expertise or core competencies], enabling it to capitalize on market opportunities and sustain long-term success.

What is the P/E ratio of Imara 2024?

The Imara P/E ratio is -7.9.

What is the P/S ratio of Imara 2024?

The Imara P/S ratio is 0.

What is the Quality Investing of Imara?

The Quality Investing for Imara is 2/10.

What is the revenue of Imara 2024?

The revenue cannot currently be calculated for Imara.

How high is the profit of Imara 2024?

The expected Imara profit is -14.21 M USD.

What is the business model of Imara

Imara Inc. is a company that specializes in developing innovative products in various industries. Its business model is focused on integrating innovative technologies in different industries to enhance performance and minimize risks. The company operates in two main areas: developing products for the healthcare industry, including medical devices, medical software, and health tech solutions, and developing products for the automotive industry, including autonomous driving, electric mobility, and connectivity. It aims to improve healthcare quality and accessibility and enhance vehicle performance and safety. Imara Inc. follows an agile, innovative, and flexible business model, adapting its offerings to meet customer needs and collaborating closely with partners and customers. It is also committed to sustainability and developing environmentally friendly products and solutions, such as electric vehicles and alternative fuels. Overall, Imara Inc.'s business model focuses on developing and offering innovative products and solutions across various industries, taking a flexible, customer-oriented approach, and continuously seeking ways to push technological boundaries and enhance performance.

What is the Imara dividend?

Imara pays a dividend of 0 USD distributed over payouts per year.

How often does Imara pay dividends?

The dividend cannot currently be calculated for Imara or the company does not pay out a dividend.

What is the Imara ISIN?

The ISIN of Imara is US45249V1070.

What is the Imara WKN?

The WKN of Imara is A2P0EP.

What is the Imara ticker?

The ticker of Imara is IMRA.

How much dividend does Imara pay?

Over the past 12 months, Imara paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Imara is expected to pay a dividend of 0 USD.

What is the dividend yield of Imara?

The current dividend yield of Imara is .

When does Imara pay dividends?

Imara pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Imara?

Imara paid dividends every year for the past 0 years.

What is the dividend of Imara?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Imara located?

Imara is assigned to the 'Health' sector.

Wann musste ich die Aktien von Imara kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Imara from 10/19/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/19/2024.

When did Imara pay the last dividend?

The last dividend was paid out on 10/19/2024.

What was the dividend of Imara in the year 2023?

In the year 2023, Imara distributed 0 USD as dividends.

In which currency does Imara pay out the dividend?

The dividends of Imara are distributed in USD.

All fundamentals about Imara

Our stock analysis for Imara Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Imara Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.